$19.40 -0.28 (-1.42%)
11/27/2009 1:00 PM

Pharmasset, Inc. (VRUS)

CAPS Rating: 2 out of 5

A clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections.

Featured Broker Partners